The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of renal function (RF) on outcomes in the adjuvant treatment of older women with breast cancer (>65 years): CALGB/CTSU 49907 (CC) ancillary data study.
Stuart M. Lichtman
No relevant relationships to disclose
Constance Cirrincione
No relevant relationships to disclose
Arti Hurria
Consultant or Advisory Role - GTx; Seattle Genetics
Research Funding - Celgene; GlaxoSmithKline
Aminah Jatoi
No relevant relationships to disclose
Maria Theodoulou
No relevant relationships to disclose
Antonio C. Wolff
Research Funding - Genentech (B)
Julie Gralow
No relevant relationships to disclose
Daniel Morganstern
No relevant relationships to disclose
Gustav Magrinat
No relevant relationships to disclose
Harvey Jay Cohen
No relevant relationships to disclose
Hyman Muss
No relevant relationships to disclose